Literature DB >> 24397615

Blood pressure is associated with occult cardiovascular disease in prospectively studied Hodgkin lymphoma survivors after chest radiation.

Ming Hui Chen1, Lauren H Blackington, Jing Zhou, Tammy F Chu, Kimberlee Gauvreau, Karen J Marcus, David C Fisher, Lisa R Diller, Andrea K Ng.   

Abstract

The objectives of this study were to prospectively screen a cohort of asymptomatic long-term survivors of Hodgkin lymphoma (HL) treated with chest irradiation for occult cardiovascular disease (CVD), and correlate screen-detected disease with prospectively measured cardiovascular risk factors (CRFs). A total of 182 HL survivors treated with chest irradiation (median follow-up time 14.8 years) were enrolled and underwent prospective CRF measurement and resting and stress echocardiography to assess coronary artery disease (CAD)/valve disease and left ventricular systolic dysfunction (LVSD). Forty-seven (26%) patients had occult CAD/valve disease and/or LVSD. LVSD was not correlated with CRFs. Controlling for treatment factors, hypertension (odds ratio [OR] = 3.0) and elevated high-sensitivity C-reactive protein (hs-CRP) (OR = 2.7) increased the likelihood of occult CAD/valve disease. Risk of CAD/valve disease rose exponentially with increasing blood pressure (BP) values, even in the normal range. Our findings suggest that BP screening may be useful in determining those survivors at greatest risk for occult CVD.

Entities:  

Keywords:  Blood pressure; Hodgkin lymphoma; cardiovascular risk factors; hs-CRP; radiation

Mesh:

Substances:

Year:  2014        PMID: 24397615     DOI: 10.3109/10428194.2013.879716

Source DB:  PubMed          Journal:  Leuk Lymphoma        ISSN: 1026-8022


  4 in total

Review 1.  How to prevent and manage radiation-induced coronary artery disease.

Authors:  Jason R Cuomo; Sean P Javaheri; Gyanendra K Sharma; Deepak Kapoor; Adam E Berman; Neal L Weintraub
Journal:  Heart       Date:  2018-05-15       Impact factor: 5.994

2.  Cumulative burden of cardiovascular morbidity in paediatric, adolescent, and young adult survivors of Hodgkin's lymphoma: an analysis from the St Jude Lifetime Cohort Study.

Authors:  Nickhill Bhakta; Qi Liu; Frederick Yeo; Malek Baassiri; Matthew J Ehrhardt; Deo K Srivastava; Monika L Metzger; Matthew J Krasin; Kirsten K Ness; Melissa M Hudson; Yutaka Yasui; Leslie L Robison
Journal:  Lancet Oncol       Date:  2016-07-25       Impact factor: 41.316

3.  Vo2peak in Adult Survivors of Hodgkin Lymphoma: Rate of Decline, Sex Differences, and Cardiovascular Events.

Authors:  Raheel Rizwan; Kimberlee Gauvreau; Cheryl Vinograd; Jessica M Yamada; Christina Mangano; Andrea K Ng; Mark E Alexander; Ming Hui Chen
Journal:  JACC CardioOncol       Date:  2021-06-15

4.  The landscape of cardiovascular care in pediatric cancer patients and survivors: a survey by the ACC Pediatric Cardio-Oncology Work Group.

Authors:  Thomas D Ryan; William L Border; Carissa Baker-Smith; Ana Barac; Matthew J Bock; Mary M Canobbio; Nadine F Choueiter; Devyani Chowdhury; Katheryn E Gambetta; Julie S Glickstein; Lavanya Kondapalli; Seema Mital; Vasum Peiris; Russell J Schiff; Robert L Spicer; Jeffrey A Towbin; Ming Hui Chen
Journal:  Cardiooncology       Date:  2019-10-23
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.